United Therapeutics Corporation (UTHR)
NASDAQ · Healthcare
United Therapeutics Corporation Net Income 2008–2025
United Therapeutics Corporation annual/quarterly net income history and growth rate from 2021 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- United Therapeutics Corporation net income for the quarter ending March 31, 2026 was 274.9 M, a 14.68% decrease year-over-year.
- United Therapeutics Corporation net income for the twelve months ending March 31, 2026 was 1.2 B, a 7.22% increase year-over-year.
- United Therapeutics Corporation annual net income for 2025 was 1.3 B, a 11.68% increase from 2024.
- United Therapeutics Corporation annual net income for 2024 was 1.2 B, a 21.35% increase from 2023.
- United Therapeutics Corporation annual net income for 2023 was 984.8 M, a 35.40% increase from 2022.
- United Therapeutics Corporation annual net income for 2022 was 727.3 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
United Therapeutics Corporation Net Income — FAQ
United Therapeutics Corporation (UTHR) net income over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
What is United Therapeutics Corporation's net income?
United Therapeutics Corporation (UTHR) reported net income of $1.33B for fiscal 2025.
Where can I see UTHR's net income history?
The chart and table above show United Therapeutics Corporation's net income by year and by quarter, including the growth rate.